More life-changing medicines are available to patients now than ever before, with new medical breakthroughs treating – and even curing – once-untreatable conditions and diseases. This type of innovation depends on the commitment of scientists, doctors, researchers, patients, investors, business leaders and others who are devoted to the discovery and development of new treatments and cures. However, access to the next generation of medicine is being threatened by short-sighted policy proposals that would chill investment in biomedical research and stifle the future innovation that so many patients continue to need.
The Alliance to Protect Medical Innovation is a nonpartisan 501(c)(4) organization, committed to fostering a national conversation on medical innovation and patient access to care that is holistic and fact-based. Toward that end, Alliance to Protect Medical Innovation evaluates policy proposals and fact-checks claims affecting biomedical innovation, as well as responds to attacks on this innovation ecosystem. We are committed to preserving the pipeline of breakthrough medicines that reduce costs within the health care system and help people live longer, healthier, and more productive lives.